Secondary Logo

Journal Logo

July/August 2019 - Volume 39 - Issue 4
pp: 293-422

A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia

DeMartinis, Nicholas III; Lopez, Rene N.; Pickering, Eve H.; More

Journal of Clinical Psychopharmacology. 39(4):318-328, July/August 2019.

Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database

Pozzi, Marco; Carnovale, Carla; Mazhar, Faizan; More

Journal of Clinical Psychopharmacology. 39(4):386-392, July/August 2019.